Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 4, 2020 |
| Target | Noachis Terra |
| Sector | Life Science |
| Buyer(s) | Oragenics |
| Deal Type | Add-on Acquisition |
| Deal Value | 2M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 5 |
| Revenue | 14M USD (2022) |
Oragenics is a developer of of novel antibiotics against infectious disease and developing effective treatments for oral mucositis. Oragenics was founded in 1996 and is based in Tampa, Florida.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science | 1 of 2 |
| Type: Add-on Acquisition | 1 of 2 |
| Country: United States | 1 of 2 |
| Year: 2020 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-23 |
Oragenics - Consumer Probiotic Business
Tampa, Florida, United States Oragenics, Inc. - Consumer Probiotic Business includes antibiotics for disease. |
Sell | $2M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-09 |
Biodextris
Laval, Quebec, Canada Biodextris, Inc. is a contract research organization providing a suite of analytical, process development and CMC consulting services for vaccines and biologics in the clinical stages of development. Biodextris is based in Laval, Quebec. |
Buy | - |
